10/08/2022

Giovannelli e Associati advised Neopharmed Gentili on the acquisition of the entire share capital of Valeas

Giovannelli e Associati assisted Neopharmed Gentili, a pharmaceutical company specializing in the commercialization of high-value therapeutic solutions controlled by Ardian together with the Del Bono family, in the acquisition of […]
14/07/2022

Giovannelli e Associati with Dedalus on the acquisition of the “healthcare division” of Lutech

Dedalus entered into an agreement for the acquisition of Lutech’s healthcare business unit, concerning the development and commercialization of digital medical records (so-called “wHealth”) and laboratory middleware (so-called “wLab”). Giovannelli […]
30/06/2022

Giovannelli e associati with P&P Holding on the sale of a majority stake to Riello Investimenti Partners Sgr

Giovannelli e Associati assisted P&P Holding, the nonoperating parent company of Protec Surface Technologies and Protim, on the sale of a majority stake to Riello Investimenti Partners Sgr. Protec Surface […]
12/05/2022

Giovannelli e Associati with a leading international institutional investor on the subscription of a secured bond

Giovannelli e Associati advised a leading international institutional investor on the subscription of a secured bond listed on the Vienna Stock Exchange in a complex refinancing operation of the IItalian […]
11/05/2022

Giovannelli e Associati with Space Capital on the acquisition of a 40% stake in Bruno Generators by Space Capital

Space Capital Club S.p.A. (“SCC”), the private capital investment platform promoted by Space Holding in October 2019, signed an agreement for the acquisition of a minority stake in Bruno Generators […]